Titan Alpha Team to Continue Critical Support for VA’s National Oncology Program (NOP) 

Washington, DC – Prometheus Federal Services (PFS) is proud to announce that Titan Alpha, its joint venture with Customer Value Partners (CVP), has been awarded a contract to continue its support for the U.S. Department of Veterans Affairs (VA) National Oncology Program (NOP) in its mission to provide cutting-edge cancer care and research services to Veterans. As cancer remains the second leading cause of death among Veterans, PFS and Titan Alpha are committed to assisting the NOP in delivering life-saving solutions and reducing the burden of cancer on those who have served.  

Cancer is a significant health concern for Veterans, with approximately 50,000 new invasive cases diagnosed each year within the Veterans Health Administration (VHA). The NOP plays a vital role in combating these statistics by leveraging precision medicine and a learning healthcare model that rapidly integrates new discoveries into clinical practice. 

As part of its ongoing support, the team will continue working with the NOP to address a backlog in VA’s cancer tumor registry. Key elements of this initiative include completing 17,500 cases, identifying cancer incidence for under-reported or unreported hospitals, and supporting the modernization and integration of the cancer registry system across VA facilities. This comprehensive effort will ensure accurate data reporting and case completion, driving improved outcomes for more than 400,000 Veterans affected by cancer. 

Having supported the NOP and VA cancer registry work since 2020, PFS and Titan Alpha will continue to make meaningful contributions as it collaborates with NOP leaders, VA, VHA, and external stakeholders to develop and implement oncology programs and services. 

The PFS/Titan Alpha team is comprised of seasoned professionals with expertise in cancer care, research, and education. These experts will support the NOP’s efforts to expand and enhance its oncology services, ensuring Veterans receive the highest quality care available. Through its ongoing work, Titan Alpha aims to help reduce cancer-related mortality rates among Veterans, improve care accessibility, and contribute to the advancement of cancer research. 

“We are honored to continue supporting the NOP’s critical work,” said Brian Camarote, PFS Vice President. “By working alongside the NOP and other VA leaders, our team can help make a lasting impact on the lives of Veterans battling cancer.” 

 

 

“And maybe most important,” adds Will Ross, Program Manager, “We are providing Veterans and their loved ones with the most precious resource of all: More time.” 

 

About Titan Alpha

Titan Alpha is a verified Service-Disabled Veteran-Owned Small Business (SDVOSB) joint venture between Prometheus Federal Services (PFS) and Atlas Research. The joint venture has been a trusted partner of the VA since its inception, delivering innovative solutions in healthcare transformation, technology, and quality improvement.